Enlivex Therapeutics Ltd
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Enlivex Therapeutics Ltd
Enlivex Therapeutics Ltd is an Israel-based development-stage biopharmaceutical company. It is focused on developing and commercializing an allogeneic drug pipeline for rebalancing immune hyper-responses. The company's Allocetra is an immunotherapy that is being developed to rebalance a life-threatening unbalanced immune system, using the immune system's own natural regulation mechanisms.
/ 
Frequently asked questions
To buy Enlivex Therapeutics Ltd stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Enlivex Therapeutics Ltd by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Enlivex Therapeutics Ltd is ENLV:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Enlivex Therapeutics Ltd has its primary listing on NASDAQ. You can trade Enlivex Therapeutics Ltd with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Enlivex Therapeutics Ltd is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Enlivex Therapeutics Ltd as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Enlivex Therapeutics Ltd.